Open AccessUnreliable Estimation of Fibrosis Regression During Treatment by Liver Stiffness Measurement in Patients With Chronic Hepatitis B
Author(s) -
Dong Ji,
Yan Chen,
Qinghua Shang,
Huabao Liu,
Lin Tan,
Jing Wang,
Yongping Chen,
Qin Li,
Qinghua Long,
Laicheng Song,
Li Jiang,
Guangming Xiao,
Zujiang Yu,
Liang Chen,
Xiaoyu Hu,
Xiaodong Wang,
Da Chen,
Zhiqin Li,
Dong Zheng,
Guofeng Chen,
Yongping Yang
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/ajg.0000000000001239
Subject(s) - medicine , gastroenterology , confidence interval , entecavir , fibrosis , logistic regression , receiver operating characteristic , odds ratio , seroconversion , prospective cohort study , chronic hepatitis , immunology , virus , lamivudine
Little reliable evidence has been reported regarding usefulness of liver stiffness measurement (LSM) for monitoring the hepatic fibrosis changes during treatment. We aimed to assess the association between changes in LSM and histological outcomes in patients with chronic hepatitis B.